CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 58,476	$ 4,330
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	18,090	16,498
Amortization of deferred financing costs	704	1,226
Losses on early extinguishment of debt	735
Change in fair value of warrant liabilities	(7,677)	26,736
Stock-based compensation	6,163	7,045
Income tax benefit from change in reserve of uncertain tax positions		(3,440)
Provision for doubtful accounts	14	55
Loss from write-offs of property and equipment	67	20
Noncash lease expense	16	61
Deferred income taxes		227
Changes in:
Accounts receivable, net	(1,475)	(14,191)
Inventories, net	4,106	(4,008)
Prepaid expenses	(1,155)	(1,123)
Other current assets	(392)	150
Other non-current assets	(22,100)	(364)
Accounts payable	(1,876)	7,490
Accrued expenses	1,442	6,164
Other current liabilities	(224)	(67)
Income tax contingency		(472)
Other long-term liabilities	7,333
Net cash provided by operating activities	62,247	46,337
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(3,433)	(2,871)
Net cash used in investing activities	(3,433)	(2,871)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of warrants	51,698	2,216
Proceeds from term loan facility	100,000
Repurchase of common shares	(18,988)
Repayment on term loan facilities	(159,639)	(51,042)
Dividends	(4,172)
Payment of deleveraging fee on term loan facilities	(5,420)
Payment of deferred financing costs	(1,340)
Net cash used in financing activities	(37,861)	(48,826)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	138	98
Net increase (decrease) in cash, cash equivalents and restricted cash	21,091	(5,262)
Cash, cash equivalents and restricted cash, Beginning of period	28,902	33,262
Cash, cash equivalents and restricted cash, End of period	49,993	28,000
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Income taxes	3,110	746
Interest	9,678	17,494
Non-cash financing transactions:
Exchange of warrants into common shares		45,261
Non cash exercise of warrants	6,793	$ 24,370
Accrued dividends cancelled on common stock	$ 2,449